Sonendo, Inc. (SONX)

USD 1.15

(-14.81%)

Gross Profit Summary of Sonendo, Inc.

  • Sonendo, Inc.'s latest annual gross profit in 2023 was 10.72 Million USD , up 2.31% from previous year.
  • Sonendo, Inc.'s latest quarterly gross profit in 2024 Q2 was 3.13 Million USD , up 55.72% from previous quarter.
  • Sonendo, Inc. reported a annual gross profit of 10.48 Million USD in annual gross profit 2022, up 25.72% from previous year.
  • Sonendo, Inc. reported a annual gross profit of 8.33 Million USD in annual gross profit 2021, up 114.57% from previous year.
  • Sonendo, Inc. reported a quarterly gross profit of 3.13 Million USD for 2024 Q2, up 55.72% from previous quarter.
  • Sonendo, Inc. reported a quarterly gross profit of 3.34 Million USD for 2023 Q1, up 0.48% from previous quarter.

Annual Gross Profit Chart of Sonendo, Inc. (2023 - 2019)

Historical Annual Gross Profit of Sonendo, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 10.72 Million USD 2.31%
2022 10.48 Million USD 25.72%
2021 8.33 Million USD 114.57%
2020 3.88 Million USD -57.16%
2019 9.06 Million USD 0.0%

Peer Gross Profit Comparison of Sonendo, Inc.

Name Gross Profit Gross Profit Difference
Acutus Medical, Inc. -3.13 Million USD 441.792%
Biotricity, Inc. 8.35 Million USD -28.311%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 7.63 Million USD -40.433%
Nemaura Medical Inc. -1.47 Million USD 826.23%
PetVivo Holdings, Inc. 739.52 Thousand USD -1349.848%
RetinalGenix Technologies Inc. -100.00 USD 10722100.0%
Telesis Bio, Inc. 16.95 Million USD 36.743%
Talis Biomedical Corporation 371 Thousand USD -2790.027%
Viveve Medical, Inc. 620 Thousand USD -1629.355%